Clinical Trial Update: Tolerability of MDMA in Schizophrenia [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes an ongoing Phase 1/Phase 2 study evaluating the tolerability of MDMA in adults with schizophrenia, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• MDMA (3,4-methylenedioxymethamphetamine)

Snippet

Sponsor: Anya Bershad, MD, PhD | Conditions: Schizophrenia | Phase 1, Phase 2 | Status: RECRUITING